key: cord-0719726-aztek7fp authors: Balkrishna, Acharya; Tomer, Meenu; Verma, Sudeep; Joshi, Monali; Sharma, Priyanka; Srivastava, Jyotish; Varshney, Anurag title: Phytometabolite profiling of Coronil, a herbal medicine for COVID‐19, its identification by mass‐spectroscopy and quality validation on liquid chromatographic platforms date: 2021-09-29 journal: J Sep Sci DOI: 10.1002/jssc.202100499 sha: 6aeb5e2f36a0f3823b5a0680f424fa2e84470b1f doc_id: 719726 cord_uid: aztek7fp Coronil is a tri‐herbal medicine consisting of immunomodulatory herbs, Withania somnifera, Tinospora cordifolia, and Ocimum sanctum. The formulation has been developed specifically as the supporting measure for COVID‐19. Current investigation is aimed to identify the phytoconstituents in Coronil utilizing ultra‐performance liquid chromatography–mass spectrometry coupled with quadrapole time of flight and to establish its quality standardization using high‐performance liquid chromatography and high performance thin layer chromatography. Out of 52 identified compounds, cordifolioside A, magnoflorine, rosmarinic acid, palmatine, withanoside IV, withanoside V, withanone, betulinic acid, and ursolic acid were quantified in 15 different batches of Coronil on validated high‐performance liquid chromatography method. Similarly, withanoside IV, withaferin A, magnoflorine, palmatine, rosmarinic acid, and ursolic acid were analyzed on high performance thin layer chromatography. Methods were validated as per the International Council for Harmonization guidelines. These methods were specific, reproducible, accurate, precise, linear (r (2) > 0.99), and percent recoveries were within the prescribed limits. The content uniformity of Coronil was ascertained using Fourier transform infrared spectroscopy. Results indicated that, validated methods were fit for their intended use and the analytical quality of Coronil was consistent across the batches. Taken together, these developed methods could drive the analytical quality control of herbal medicines such as Coronil, and other formulations containing similar chemical profiles. The pandemic of novel coronavirus disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is unique and unprecedented in several aspects. It has opened the battlefront in healthcare systems across the globe [1] . Despite worldwide efforts to contain it, the pandemic has been continuing to spread. This demands for clinically proven prophylaxis and therapeutic strategies without any harmful aftermaths to the human race [2] . Thus, at a time of this worldwide anxiety, dimensions of pandemic demand imperative longterm solutions of all knowledge systems available globally [3] . In India, several initiatives have been taken to utilize Ayurvedic therapies as a preventative measure against COVID-19. Drinking warm water all through the day and consumption of herbal tea are among a few of the suggested Ayurvedic therapies [4] . The crux of the matter is that prevention is better than cure. Ayurveda, one of the world-renowned forms of Indian traditional medicine, showcases a great deal of immunity-boosting therapies. Coronil is one such formulation, which is based on the trusted classical principles of Ayurveda. Coronil is a tri-herbal medicine enriched with the extracts of three potential antiviral and immunomodulatory herbs, Tinospora cordifolia (Saptaśirikā aromapatrā, Giloy, heartleaved moonseed), Withania somnifera (Aśvagandhakah . svāpakarah . , Ashwagandha, winter cherry), and Ocimum sanctum (Sumañjarikā rāmā, Tulsi, holy basil). The Coronil formulation has emerged as the viable option for combating COVID-19 contagion. Tinospora cordifolia holds a special position in Ayurvedic literature for its diverse therapeutic application. The major phytocomponents reported in this medicinal plant are cordifolioside A, magnoflorine, tinocordiside, palmatine, and syringin. Metabolites of this herb have been reported to possess immune-boosting properties [5] . The antiviral potential of the palmatine alkaloid has been established against the main protease complex (Mpro) of SARS-CoV-2 [6] . Ocimum sanctum is often referred to as an "elixir of life" for its vast array of medicinal properties [7] . Pharmacologically, O. sanctum has been explored in hundreds of scientific studies including in vitro, animal and human experiments. Experimental evidences have also demonstrated that selected naturally occurring compounds from O. sanctum exhibit antiviral activities [8] . In same line, Wen and co-workers evaluated betulinic acid, one of the O. sanctum compound, for its anti-SARS-CoV activity in Vero-E6 cells on a cell-based cytopathic effect assay [9] . The compounds such as ursolic acid, carnosol, rosmarinic acid, cirsilineol, apigenin, eugenol, and cirsimaritin present in O. sanctum upregulate IL-2 and IFN-ϒ, and downregulate IL-1β, which represent a major defense mechanism to assess T-cell-dependent antibody responses [10] . Withania somnifera has been considered with a combination of versatile immunomodulatory phytoconstituents. Compounds of W. somnifera, Withaferin A and withanone, have been shown to significantly block the entry of SARS-CoV-2 in host cells [11] . Pathophysiology of SARS-CoV-2 indicates that the virus invades the host cell receptor angiotensin-converting enzyme 2 (ACE2) through its spike protein receptor binding domain (RBD). Withanone and tinocordiside docked very well in the binding interface of ACE2-RBD complex and significantly attenuated the electrostatic component of binding free energies of ACE2-RBD complex [12, 13] . Docking result postulates that natural phytochemicals indeed have the potential to fight against COVID-19 and its pathogenicity. With this rationality, innate potentials of W. somnifera, T. cordifolia, and O. sanctum are utilized to formulate "Coronil" (referred as CNT now onwards), as an effective pharmaceutical agent to combat SARS-CoV-2 infectivity [14, 15] . To assure the safety and efficacy of these traditional medicines, it is critical to establish their comprehensive qualitative assessment methods [16] . The key ingredients of CNT constitute a plethora of bioactive secondary metabolites, which makes the simultaneous determination of active ingredients necessary for its comprehensive quality evaluation. This encouraged us to develop rapid, sensitive, and reliable analytical methods using RP-HPLC with photo diode array detector (RP-HPLC-PDA), high performance thin layer chromatography (HPTLC), and FTIR spectroscopy as strategic tools for the CNT quality assessment. UHPLC/MS coupled with quadrapole TOF (UHPLC/MS-ToF) analyzer is one of the foremost effective techniques for ionizable moieties with high mass precision [17] . The CNT analytical evaluation was initiated by screening of potential biomarkers utilizing UHPLC/MS-ToF platform. For CNT, selected markers, rosmarinic acid, magnoflorine, palmatine, withaferin A, withanoside IV, withanoside V, cordifolioside, betulinic acid, withanone, and ursolic acid were quantified simultaneously, by utilizing the developed and validated RP-HPLC-PDA and HPTLC techniques for the first time. The stability of the formulation was also evaluated under different solvents, temperature, and light conditions. The developed RP-HPLC-PDA method was then utilized for the quantification of the target compounds in 15 different batches of CNT. Moreover, FTIR fingerprinting was performed to ascertain batch-to-batch consistency of CNT formulation. The HPLC and LCMS grade solvents acetonitrile and methanol were obtained from E-Merck and Honeywell (Germany), respectively. Analytical grade solvents, glacial acetic acid, and formic acid were procured from Honeywell, Germany; p-anisaldehyde, sulphuric acid, toluene, and ethyl acetate were purchased from E-Merck, Germany. Deionized water, purified by a Milli-Q system (Millipore, USA), was used throughout the study. 2.2.1 Ultra high performance liquid chromatography-mass spectrometry coupled with quadrapole time of flight analysis Preparation of Coronil sample solution 10 mL of methanol:water (80:20) was added to 100 mg of powdered CNT sample and sonicated for 15 min. The solution was then centrifuged for 5 min at 5000 rpm and filtered using a 0.22 μm nylon filter. The filtered solution was used for the analysis. The analysis was performed on a Xevo G2-XS QToF Waters Corporation (MA, USA) with Acquity UPLC I-Class and Unifi software (Waters Corporation, USA). The separation was carried out using Nucleodur C18 Gravity column (100 × 2.0 mm, 1.8 μm) (Macherey-Nagel, USA). The column was maintained at 35 • C and the sample temperature was kept at 20 • C during the analysis. The main working parameters for MS were: ionization type-ESI, mode-MS E , acquisition time 62 min, mass range (m/z) 50−1200 m/z, low collision energy 6 eV, high collision energy 20−40 eV (ramp), cone voltage 40 V, capillary voltage 1.5 kV (for positive mode), 2 kV (for negative mode), source temperature 120 • C, desolvation temperature 500 • C, cone gas flow 50 L/h, desolvation gas flow 900 L/h. Mass was corrected during acquisition, using an external reference (Lock-Spray) consisting of 0.2 ng/mL solution of leucine enkephalin (Waters , USA) infused at a flow rate of 10 μL/min via a lock-spray interface, gen- The marker components in CNT were identified and affirmed by their respective mass ion, fragmentation pattern, offline and online mass spectral database, and related literature. Data acquisitions were executed under positive (+ve) and negative (−ve) mode of ionization utilizing full spectrum scan. Stock solutions of cordifolioside A, magnoflorine, rosmarinic acid, palmatine, withanoside IV, withaferin A, withanoside V, withanone, betulinic, and ursolic acid (1000 ppm) were prepared by dissolving accurately weighed standards in methanol:water (80:20), to generate 50 ppm working standard solutions. For the HPTLC analysis, the stock solutions of reference standards were diluted using same solvent to prepare working standard solutions of 100 ppm for withanoside IV, withaferin A, rosmarinic acid, and ursolic acid. Whereas, 20 and 5 ppm standard solutions were prepared for magnoflorine and palmatine, respectively. Preparation of Coronil sample solution 0.5 g of powdered CNT (batch #ACNT 001) was added to 10 ml methanol:water (80:20) and sonicated for 30 min. The sonicated solution was centrifuged for 5 min at 10 000 rpm and filtered through a 0.45 μm nylon filter and used for the analysis of cordifolioside A, magnoflorine, rosmarinic acid, palmatine, withanoside IV, withaferin A, withanoside V, withanone, betulinic, and ursolic acid. For HPTLC analysis, 0.5 g of CNT sample (batch #A CNT 002) was added with 5 ml of same diluent. The solution was sonicated for 30 min, centrifuged for 5 min at 10 000 rpm and filtered through a 0.45 μm nylon filter for the investigations of withanoside IV, withaferin A, magnoflorine, palmatine, rosmarinic acid, and ursolic acid. RP-HPLC-PDA analysis was performed on Prominence-XR HPLC system (Shimadzu, Japan) equipped with Quaternary pump (NexeraXR LC-20AD XR), PDA detector (SPD-M20 A), Auto-sampler (Nexera XR SIL-20 AC XR), Degassing unit (DGU-20A 5R), and Column oven (CTO-10 AS VP). A solvent system of water containing 0.1% orthophosphoric acid adjusted to pH 2.5 with diethylamine (solvent A) and acetonitrile (solvent B) was selected. Gradient elution program used during the analysis consisted of 5% B for 0−10 min, 5−15% B from 10−20 min, 15−25% B from 20−40 min, 25−65% B from 40−60 min, 65−90% B from 60−65 min, 90−5% B from 65−66 min, and 5% B from 66−70 min. The chromatograms acquired using a Shimadzu Shim pack, GIST-HP C18 (3 μm, 3 × 100 mm) (Shimadzu, Japan) with a flow rate of 0.7 ml/min. The chromatographic detection of all the analytes was performed using a PDA detector at 325, 227, and 210 nm. The temperature of the column was kept at 30 • C and the sample injection volume was 5 μL. palmatine, and magnoflorin, after development, plates were removed and dried using air dryer. For fingerprinting, the plates were visualized at 254, 366 nm, and under white light after derivatization using anisaldehyde sulfuric acid reagent (prepared by adding 1 mL of p-anisaldehyde in 70 mL methanol, 20 mL glacial acetic acid, and 10 ml of sulfuric acid. The prepared reagent was stored in an amber colored bottle). For visualization, the densitometric scanning was performed using TLC Scanner 4, with slit dimension (6.00 × 0.45 mm) and 20 mm/s scanning speed at the wavelengths of 530 nm for withaferin A, rosmarinic acid, and ursolic acid and 254 nm for withanoside IV, palmatine, and magnoflorine. For quantification, the plates were scanned at 230 nm for withaferin A, 265 nm for magnoflorine, 330 nm for palmatine, and rosmarinic acid. For ursolic acid, the developed plate was derivatized using anisaldehyde sulphuric acid and scanned at 530 nm. The analysis was performed on Cary 630 FTIR (Agilent technologies, Malasyia) set at attenuated total reflection mode. Spectra were scanned over the frequency range of 650-4000 cm −1 with a spectral resolution of 16 cm −1 . For the spectrum acquisition, a powdered CNT sample from 15 different batches was placed onto the attenuated total reflection crystal. Ten marker components namely, cordifolioside A, magnoflorine, rosmarinic acid, palmatine, withanoside IV, withaferin A, withanoside V, withanone, betulinic, and ursolic acid were validated using RP-HPLC-PDA as per International Council on Harmonisation [ICH-Q2(R1)] guidelines [18] . System suitability was affirmed before the experimental analysis. The specificity of the developed method was evaluated by injecting 5 μL of the solvent blank (methanol:water, 80:20) at 325, 210, and 227 nm in both standard and sample matrices. Three-point peak purity of the analytes was considered to ensure the specificity of the developed method. For linearity, working standard solutions were prepared separately in different concentration ranges 0.25-100 μg/mL, by diluting the stock solution with methanol. The calibration curve was plotted between peak area and respective concentrations to Table 1 , and Supplementary Figures S1A to S1G for detailed information The method was validated for quantification of withanoside IV, withaferin A, magnoflorine, palmatine, rosmarinic acid, and ursolic acid in CNT samples. Linearity was performed by plotting calibration curve similar to RP-HPLC. The LOD and LOQ were calculated by using the values of slopes and intercepts of the calibration curve. The intraday and interday precisions (n = 9) were evaluated by calculating %RSD at three different concentrations. The recovery of the method was evaluated using the standard addition method. The analysis was performed in triplicates at 80, 100, and 120% i.e. n = 9 by adding known quantities of reference standards to the CNT formulation. To assure the unwavering reliability of the created and approved RP-HPLC-PDA strategy, quantitative investigation of magnoflorine, rosmarinic acid, palmatine, withanoside IV, withaferin A, and withanoside V was done on For HPTLC, the concentration of withanoside IV, withaferin A, magnoflorine, palmatine, rosmarinic acid, and ursolic acid were determined by applying the samples (2-4 μL) along with the reference standards. The quantity of the markers was calculated using the regression equation obtained from the standard calibration curves. Statistical analyses were performed using Graph Pad Prism 7.0 (Graph pad Software, San Diego, CA, USA). Characterization of the marker analytes was performed using Unifi software Waters Corporation (MA, USA). RP-HPLC-PDA analysis was performed on LabSolutions (Shimadzu, Japan). HPTLC studies were performed using win-CATS software (CAMAG, Muttenz, Switzerland). FTIR analysis was performed on MicroLab software (Agilent, Malasiya). A total of 52 compounds were recognized using UHPLC/MS-ToF, where 36 compounds were identified in the positive mode of ionization ( Figure 1A , Table 1 ) and 39 compounds were identified in the negative mode of ionization ( Figure 1B, Table 1 ). Twenty-three compounds were found to be common in both the ionization mode. The recognizable proof of compounds relied on the information of mass fragmentation patterns and accurate mass measurement of the targeted analytes. Further confirmation was achieved using an in-house spectral library and literature search ( Figure S1 , Table 1 ). Mass fragmentation pattern ascertained the presence of cordifolioside A, magnoflorine, palmitine in CNT, consequently, these markers were Furthermore, withaferin A, withanoside IV, withanoside V, and withanone were identified and chosen as the signature markers for W. somnifera. Thus, for RP-HPLC-PDA analysis, 10 marker analytes, cordifolioside A, magnoflorine, rosmarinic acid, palmatine, withanoside IV, withaferin A, withanoside V, withanone, betulinic, and ursolic acid were selected for standardization of CNT. Whereas, for HPTLC, six components viz., withanoside IV, withaferin A, magnoflorine, palmatine, ursolic acid, and rosmarinic acid were selected. The marker components were selected based on their established potential immunomodulatory activity and availability. Chromatographic separation of 10 markers portrayed a big challenge, as these compounds have exceptionally wide as well as a close range of polarity index. The aim was to separate the targeted components with a compatible solvent system, gradient elution was therefore carried out so as to ensure that the elution of all the compounds was completed within a short time. Both reverse phase and normal phase were also tried but due to the prominence of polar moieties, reverse phase chromatography was found to be the best solution for separation of the targeted analytes. After several trials of mobile phase and column optimization, the aforementioned method in the above section, effectively ensured that the needed separation of the targeted analytes was with acceptable peak shape and resolved between the peaks (Figure 2 ). Flow rates between 0.5 and 1 mL/min were tried for the current study. A flow rate of 0.7 mL/min gave reasonable separation of the compounds with high theoretical plates. Choice of the wavelength was quite difficult as all these compounds have different structures, distinctive spectra, and molar absorptivity. For that purpose, the chromatographic detection of the analytes was performed using a PDA detector which scans the entire spectrum (190 to 800 nm) simultaneously. Absorption maxima for cordifolioside A, magnoflorine, withanoside IV, withaferin A, withanoside V, and withanone was found at 227 nm. For rosmarinic acid and palmatine at 325 nm and for betulinic acid and ursolic acid the same was observed at 210 nm. The overlaid chromatograms of standard and sample depicted similar retention time confirming the targeted molecule, which was used for calculating the amount of active moieties in CNT. Thus, from the optimized RP-HPLC it is evident that targeted anaytes in CNT are well separated and their quantification can be carried out with adequate precision. Optimization indeed is a prime step of method development [19] . was chosen for withanoside IV, magnoflorine, and palmatine with Rf value 0.14, 0.19, and 0.34, respectively. The chromatographic scanning was performed at wavelengths 530 and 254 nm (Figure 3 ). Due to lack of the chromophore moieties, triterpenoids show low UV absorptivity. Derivatization with the chemical reagents is used to detect these classes of compounds in the visible region. In our investigation, for the fingerprinting and quantitative analysis of usrolic acid, derivatization was employed using anisaldehyde sulphuric acid. Post derivatization results revealed a bright purple-colored band (Rf 0.70), corresponding to ursolic acid at 530 nm indicating the specificity of the developed method. The RP-HPLC-PDA and HPTLC methods were validated in terms of linearity, limits of quantification, detection, accuracy, and precision. Determination of system suitability, specificity, and robustness was additionally done for RP-HPLC-PDA (Tables 2 and 3 ). For RP-HPLC-PDA the specificity of the method was monitored by comparing the chromatograms of solvent blank, standard mix, and sample matrix. In solvent blank chromatogram, no peaks were detected close to the retention time of the selected marker components. Moreover, the peak purity of all the targeted analytes was found to be >0.980 confirming that there is no interference of the solvent, diluent, and other close eluting compounds at the RT of the marker components ( Figure 2 ). The obtained LOD and LOQ values for cordifolioside A, rosmarinic acid, palmatine, withaferin A, withanoside V, and withanone were 0.5 and 1.0 μg/g, respectively. Similarly, for withanoside IV and betulinic acid those were 1.0 and 2.0 μg/g, whereas, for magnoflorine 0.1 and 0.25 μg/g and for ursolic acid it was 0.5 and 2.0 μg/g ( Table 2 ). For HPTLC, the LOD and LOQ values were found to be (1.73 and 5.26 μg/g), (0.87 and 2.63 μg/g), (8.81 and 26.71 μg/g), (0.03 and 0.10 μg/g), (0.10 and 0.31 μg/g), (0.51 and 1.53 μg/g) for withanoside IV, withaferin A, magnoflorine, palmatine, rosmarinic acid, and ursolic acid, respectively ( Table 3) . The observed results were found to be within the acceptance criteria (NMT 33% and NMT 10% for LOD and LOQ, respectively). For reported RP-HPLC and HPTLC methods, the value obtained for LOD and LOQ (Tables 2 and 3 , respectively) indicated that the method is sensi-tive to detect and quantify the target analytes at very low level. For RP-HPLC-PDA and HPTLC, the calibration curve exhibited a good linear relationship for all compounds with correlation coefficient ranging from 0.997 to 0.999 (Tables 2 and 3 ). Thus, indicating that the proposed analytical methods are linear and suitable for the quantification of the targeted analytes in CNT. The results of the regression equation are depicted in Figures S2 and S3 . Based on LOD, LOQ, and linearity determinations for RP-HPLC, the lowest working range was found to be 5 μg/g for magnoflorine, 20 μg/g for cordifolioside A, rosmarinic acid, palmatine, withaferin A, withanoside V, withanone and 40 μg/g for withanoside IV, betulinic acid and ursolic acid. Whereas, higher range for all the targeted molecules was 20 00 μg/g. The working range of HPTLC was 200-600 μg/mL for withanoside IV, 600-1400 μg/mL for withaferin A, 40-100 μg/mL for magnoflorine, 5-25 μg/mL for palmatine, 100-350 μg/mL for rosmarinic acid, and 200-800 μg/mL for ursolic acid (Tables 2 and 3 ), indicating that these methods are applicable for a wide concentration range of active molecules in CNT. Accuracy refers to the closeness of the agreement between the true value and obtained results [18] . The accuracy of all the targeted signature analytes, by both the analytical methods was evaluated by the standard addition method. The recoveries of the marker compounds at aforementioned concentrations are ranged from 93 to 100% (Tables 2 and 3 ). The results proved that the established RP-HPLC-PDA and HPTLC method is accurate for the simultaneous determination of phytocomponents in CNT. The precision of the developed RP-HPLC-PDA method was verified by intraday and interday (n = 6) analysis. %RSD was computed and was within the permissible criteria of ˂5% for magnoflorine, rosmarinic acid, palmatine, withanoside IV, withaferin A, and withanoside V, confirming that the method was sufficiently precise. Whereas, cordifolioside A, withanone, betulinic acid, and ursolic acid, were found below the quantification limit ( Table 2 ). The HPTLC method was also found to be precise (Table 3) , with repeatability and intermediate precision within the acceptance criteria of ˂2%. The robustness of the analytical method should confirm the reliability of analysis concerning deliberate variations in the parameters. Variations in terms of column and flow rate did not produce any significant effect on the measured values. The %RSD of the 12 determinations, for the change in columns (lot number 20A00104 and 20A00105) (n = 12) and 18 determinations with change in flow rate from 0.665 to 0.7 mL/min and 0.735 mL/min (n = 18) were found to be within the prescribed limits (Table 2) , indicating the robustness of the method. Stability was performed under different conditions for 24 h to check the quality of the product during analysis and storage. Figure 4 shows the 3D graphs for the stability analysis. The targeted analytes (Z-axis) were plotted against concentration (Y-axis) at different time intervals (X-axis) with variation in temperature and light conditions. A methanolic solution of CNT (up to 50 mg/mL) was found to be stable for 24 h. Furthermore, the results also indicated that the CNT formulation of 100 mg/mL in 0.5% methylcellulose is stable for 24 h. The developed and validated analytical method was successfully used for the simultaneous determination of Figure 5) . It was observed that the concentrations of cordifolioside A, withanone, betulinic acid, and ursolic acid were below the limit of quantification ( Figure 6 ). Accumulation of secondary metabolites in the plant material is often influenced by several factors; the most important of them are seasonal and geographical. Thus, it is evident that the intricacies of herbal formulations demand a multimarker standardization approach because the phytochemicals ought to vary due to different external and internal factors. The developed and validated HPTLC method for the simultaneous estimation of six marker components was further applied to determine the content of biomarkers in CNT. For HPTLC, the column bar graph was plotted which depicts the quantity of each targeted analyte (Figure 7) . The results indicated that the proposed HPTLC strategy is pertinent for the analysis of the aforementioned analytes in the CNT formulation. In recent years, FTIR has emerged as a cost-effective analytical tool for verifying batch-to-batch consistency of the formulation [20] . In this study, 52 phytometabolites were identified in Coronil by a rapid UPLC/MS-ToF technique, ensued by simultaneous estimation of the selected ten and six markers using RP-HPLC-PDA and HPTLC, respectively. To establish consistency of validated method, concurrent determination of magnoflorine, rosmarinic acid, palmatine, withanoside IV, withaferin A, and withanoside V in 15 different batches of Coronil was studied by RP-HPLC. Content uniformity was also established by FTIR spectroscopy fingerprinting in the same Coronil batches. The results suggest that method development is significant to ensure batch-to-batch consistency in terms of quality. Developed methods can be utilized by herbal manufacturers as quality control strategy for herbal extracts and formulations containing similar herbs such as Withania somnifera, Ocimum sanctum, and Tinospora cordifolia for their reproducible pharmacological effects. The authors thank Mr. Vallabh Mulay for discussions and support for phytochemical analysis. The authors gratefully acknowledge the help rendered by Dr. Seema Gujral for her thoughtful inputs during manuscript review. We extend our gratitude to Ms. Priyanka Kandpal, Mr. Tarun Rajput, Mr. Gagan Kumar, and Mr. Lalit Mohan for their swift administrative supports. The data that support the findings of this study are available from the corresponding author upon reasonable request. This research received no external funding. This presented work has been conducted using internal research funds from Patanjali Research Foundation Trust, Haridwar, India. The test articles were provided by Divya Pharmacy, Haridwar, Uttarakhand, India. Acharya Balkrishna is an honorary trustee in Divya Yog Mandir Trust, that governs Divya Pharmacy, Haridwar. In addition, he holds an honorary managerial position in Patanjali Ayurved Ltd., Haridwar, India. Other than providing the test formulations, Divya Pharmacy was not involved in any aspect of research reported in this study. All other authors have declared no conflict of interest. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis COVID-19 infection: the China and Italy perspectives COVID-19: a promising cure for the global panic Immunity against covid-19: potential role of ayush kwath Immunomodulatory active compounds from Tinospora cordifolia Anti-SARS-CoV-2 main protease complex (Mpro) activity of Palmatine Unravelling the genome of holy basil: an "incomparable" "elixir of life" of traditional Indian medicine Evaluation of antiviral activity of Ocimum sanctum and Acacia arabica leaves extracts against H9N2 virus using embryonated chicken egg model Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus Phytochemical constituents and pharmacological activities of Ocimum sanctum (Tulsi): a review Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor Withanone from Withania somnifera attenuates SARS-CoV-2 RBD and host ACE2 interactions to rescue spike protein induced pathologies in humanized zebrafish model Tinocordiside from Tinospora cordifolia (giloy) may curb SARS-CoV-2 contagion by disrupting the electrostatic interactions between host ACE2 and viral s-protein receptor binding domain Application of humanized zebrafish model in the suppression of SARS-CoV-2 spike protein induced pathology by tri-herbal medicine coronil via cytokine modulation Coronil, a tri-herbal formulation, attenuates spike-protein-mediated SARS-CoV-2 viral entry into human alveolar epithelial cells and pro-inflammatory cytokines production by inhibiting spike protein-ACE-2 interaction How can synergism of traditional medicines benefit from network pharmacology? LC/MS based tools and strategies on qualitative and quantitative analysis of herbal components in complex matrixes International Conference on Harmonization (ICH-Q2 R1). Validation of Analytical Procedures: Text and Methodology Current challenges and future prospects in chromatographic method development for pharmaceutical research Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy Phyto-metabolite profiling of Coronil, a herbal medicine for COVID-19, its identification by mass-spectroscopy and quality validation on liquid chromatographic platforms